Published in Eur J Cardiovasc Prev Rehabil on April 01, 2009
Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health. Circ Cardiovasc Qual Outcomes (2010) 1.93
Socioeconomic inequalities in occupational, leisure-time, and transport related physical activity among European adults: a systematic review. Int J Behav Nutr Phys Act (2012) 1.62
Association between area-level socioeconomic deprivation and a cluster of behavioural risk factors: cross-sectional, population-based study. J Public Health (Oxf) (2010) 1.16
"Getting sicker quicker": does living in a more deprived neighbourhood mean your health deteriorates faster? Health Place (2011) 1.01
The importance of antioxidant micronutrients in pregnancy. Oxid Med Cell Longev (2011) 1.01
The Well London program--a cluster randomized trial of community engagement for improving health behaviors and mental wellbeing: baseline survey results. Trials (2012) 0.90
Neighborhood deprivation is strongly associated with participation in a population-based health check. PLoS One (2015) 0.86
Variety and quality of healthy foods differ according to neighbourhood deprivation. Health Place (2012) 0.85
Social deprivation and exposure to health promotion. A study of the distribution of health promotion resources to schools in England. BMC Public Health (2010) 0.84
Area deprivation across the life course and physical capability in midlife: findings from the 1946 British Birth cohort. Am J Epidemiol (2013) 0.77
Lifecourse socioeconomic status and cancer-related risk factors: Analysis of the WHO study on global ageing and adult health (SAGE). Int J Cancer (2016) 0.75
Education and the Relationship Between Supermarket Environment and Diet. Am J Prev Med (2016) 0.75
Socioeconomic position early in adolescence and mode of delivery later in life: findings from a Portuguese birth cohort. PLoS One (2015) 0.75
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (2007) 37.88
Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet (2008) 25.83
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol (2003) 16.71
Priority actions for the non-communicable disease crisis. Lancet (2011) 15.18
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Cohort Profile: the 'children of the 90s'--the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol (2012) 11.79
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J (2003) 8.51
Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med (2004) 8.07
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94
Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet (2008) 7.31
Indicators of socioeconomic position (part 1). J Epidemiol Community Health (2006) 7.09
Cohort Profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J Epidemiol (2012) 6.91
Birth weight and risk of type 2 diabetes: a systematic review. JAMA (2008) 6.73
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet (2004) 6.37
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Where is the evidence that animal research benefits humans? BMJ (2004) 5.99
Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81
Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2013) 5.57
Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review). Am J Hypertens (2011) 5.54
C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet (2005) 5.51
Childhood obesity. Lancet (2010) 5.47
Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2011) 5.30
Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol (2004) 5.07
Complex interventions to improve physical function and maintain independent living in elderly people: a systematic review and meta-analysis. Lancet (2008) 4.97
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ (2003) 4.74
Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev (2011) 4.72
GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71
The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis (2007) 4.34
Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet (2008) 4.32
Exercise for depression. Cochrane Database Syst Rev (2013) 4.30
Chronic diseases and injuries in India. Lancet (2011) 4.27
Raising the priority of preventing chronic diseases: a political process. Lancet (2010) 4.16
Association of maternal weight gain in pregnancy with offspring obesity and metabolic and vascular traits in childhood. Circulation (2010) 4.12
Genome-wide association study identifies five loci associated with lung function. Nat Genet (2009) 4.10
Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med (2011) 3.94
Measuring socio-economic position for epidemiological studies in low- and middle-income countries: a methods of measurement in epidemiology paper. Int J Epidemiol (2012) 3.93
Indicators of socioeconomic position (part 2). J Epidemiol Community Health (2006) 3.87
Prevention of chronic diseases: a call to action. Lancet (2007) 3.87
Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ (2002) 3.87
Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes (2008) 3.76
Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75
Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med (2007) 3.71
NHS waiting lists and evidence of national or local failure: analysis of health service data. BMJ (2003) 3.60
Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest (2008) 3.51
(Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol (2004) 3.43
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2003) 3.43
Lessons from the withdrawal of rofecoxib. BMJ (2004) 3.33
The underlying risk of death after myocardial infarction in the absence of treatment. Arch Intern Med (2002) 3.32
Secular trends in mortality by stroke subtype in the 20th century: a retrospective analysis. Lancet (2002) 3.29
Exercise for depression. Cochrane Database Syst Rev (2009) 3.23
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Chronic diseases and calls to action. Int J Epidemiol (2008) 3.11
WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE). Bull World Health Organ (2005) 3.09
Non-communicable diseases in low and middle-income countries: a priority or a distraction? Int J Epidemiol (2005) 3.06
Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03
Quality in epidemiological research: should we be submitting papers before we have the results and submitting more hypothesis-generating research? Int J Epidemiol (2007) 3.03
Genetic epidemiology and public health: hope, hype, and future prospects. Lancet (2005) 3.00
Admissions for myocardial infarction and World Cup football: database survey. BMJ (2002) 2.99
Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J (2004) 2.91
How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med (2004) 2.89
Data dredging, bias, or confounding. BMJ (2002) 2.87
Educational and organisational interventions used to improve the management of hypertension in primary care: a systematic review. Br J Gen Pract (2005) 2.83
Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res (2011) 2.83
Association of body mass index with suicide mortality: a prospective cohort study of more than one million men. Am J Epidemiol (2005) 2.82
Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study using data from 4 UK cohorts. Am J Clin Nutr (2010) 2.82
Treatment and prevention of obesity--are there critical periods for intervention? Int J Epidemiol (2006) 2.81
Objective measures of physical capability and subsequent health: a systematic review. Age Ageing (2010) 2.78
Manufacturing epidemics: the role of global producers in increased consumption of unhealthy commodities including processed foods, alcohol, and tobacco. PLoS Med (2012) 2.71
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 2.70
Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control (2008) 2.68
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain (2005) 2.67
Associations of gestational weight gain with maternal body mass index, waist circumference, and blood pressure measured 16 y after pregnancy: the Avon Longitudinal Study of Parents and Children (ALSPAC). Am J Clin Nutr (2011) 2.67
Association between falls in elderly women and chronic diseases and drug use: cross sectional study. BMJ (2003) 2.63